Audeara’s chip-level AI licensing partnership moves into commercial production
Audeara Limited (ASX: AUA) has confirmed that its chip-level AI Audio Licensing Agreement with OPTEK Microelectronics Co., Ltd has entered commercial production across two customer product programs, marking the first revenue-generating deployment under its fee-per-chip licensing model.
The Company received its first commercial production purchase orders valued at approximately A$31,000 in aggregate, following an extensive period of development, technical validation and customer acceptance alongside Optek.
Audeara has been explicit that these initial orders are not financially material in isolation. The significance lies in the commercial and technical validation of the chip-level AI licensing strategy, referencing prior disclosures made in ASX announcements dated 16 and 18 December 2025.
When big ASX news breaks, our subscribers know first
What the milestone validates
The transition into commercial production validates Audeara’s ability to:
-
Adapt and optimise its proprietary AI audio algorithms for deployment on third-party semiconductor platforms
-
Satisfy the technical requirements of a semiconductor partner and its customer
-
Progress an AI audio program through development, validation and customer acceptance
-
Monetise its technology through a scalable, capital-light fee-per-chip licensing structure
This represents the successful transition of the Optek partnership from technology development into commercial deployment. The deployment includes Audeara’s AI noise-reduction technology, where efficient on-chip implementation is an important capability for audio applications requiring low latency, constrained processing resources and high-quality speech and sound processing.
James Fielding, Chief Executive Officer, Audeara
“This is an important milestone for Audeara as we have demonstrated that our AI Audio technology can be successfully deployed ‘on chip’ which makes us a valuable provider moving forwards. This first deployment validates both our capital light licensing strategy and proves a pathway for our technology to be deployed efficiently and at scale. Companies who can adapt existing silicon and extract as much capability out of a semiconductor platform as possible will have a competitive advantage. We’ve just proven we can do that.”
How chip-level AI audio licensing works
Chip-level, or on-chip, AI deployment means the algorithms run directly on third-party semiconductor platforms. This efficiency matters where latency and processing power are constrained.
The fee-per-chip model is a scalable, capital-light licensing structure. For investors, this structure offers scalable revenue that grows as licensed products are ordered and manufactured.
The applicable licence fee is commercially sensitive and undisclosed, as disclosure would be likely to prejudice Audeara’s position in current and future licensing negotiations. Future revenue will be recognised as additional licensed products are ordered and manufactured under approved production programs.
| Element | Detail | Investor Impact |
|---|---|---|
| Model | Fee-per-chip licensing | Capital-light, scalable |
| Initial orders | ~A$31,000 aggregate | Not material in isolation |
| Deployment | On-chip AI noise-reduction | Technical foundation for roadmap |
| Partner | OPTEK (20+ yrs DSP expertise) | Access to global OEM/ODM customers |
About Optek and why the partner matters
OPTEK is described as a leading provider of chip-level audio DSP solutions, with over 20 years of expertise in professional audio DSP SoC design. The company delivers end-to-end intelligent audio chipset solutions to the global audio industry, integrating AI and audio technologies across consumer electronics, professional audio and new-energy vehicles.
Optek’s chip products are in use with an array of international consumer electronics brands, including:
-
SHARP
-
PHILIPS
-
TOSHIBA
-
Panasonic
-
Pioneer
-
TEAC
-
ONKYO
These established relationships represent a potential distribution pathway that could give Audeara’s technology scale. Notably, these brands are Optek’s customers, and the announcement does not confirm any specific product program between Audeara and these named companies.
What comes next for Audeara’s technology roadmap
The capability demonstrated through these initial programs is relevant to Audeara’s broader technology roadmap. The Company is continuing to adapt and optimise its AI technology suite for potential use across consumer audio, hearables, assistive-listening products and hearing aids.
The Optek program is one of several capital-light commercialisation structures Audeara has been advancing in parallel; the Clinico white-label partnership, which generated $164,000 in purchase orders across three programs, demonstrates a similar pattern of leveraging established partner distribution channels to extend the company’s technology reach without direct market entry costs.
The ability to deploy AI-enabled noise reduction and speech-enhancement algorithms efficiently on existing semiconductor platforms provides a technical foundation for future applications where processing efficiency, latency and speech clarity are critical.
Future revenue will be recognised as additional licensed products are ordered and manufactured under approved customer production programs. No specific timelines or forward revenue figures were disclosed.
For investors, the milestone de-risks the licensing strategy by proving commercial execution. It positions Audeara as a validated AI audio intellectual property provider across the hearing-health and consumer audio markets, though the near-term financial contribution remains modest by the Company’s own assessment.
For investors exploring how the hearing-health and assistive-listening segments fit into Audeara’s commercial strategy, our detailed coverage of Audeara’s Shokz hearing-health distribution deal examines the exclusive Australian agreement targeting 600,000 school-aged children through pre-funded government and charitable delivery channels.
Ready to Learn More About Audeara’s Chip-Level AI Licensing Strategy?
Audeara’s entry into commercial production with OPTEK validates its capital-light, fee-per-chip licensing model as a scalable pathway to monetising its proprietary AI audio technology across consumer electronics, hearables and hearing-health applications.
To explore the full scope of Audeara’s commercial strategy and technology roadmap, visit the Audeara company profile on StockWire X for the latest coverage and investor updates.